C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/64 (2006.01) A61K 31/4412 (2006.01) C07D 401/10 (2006.01) C07D 417/10 (2006.01)
Patent
CA 2741325
Compounds having the formula (I) wherein R1, R2, R3a, R3b, R3c, R4, R5 and p are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
La présente invention concerne des composés de formule (I) dans laquelle R1, R2, R3a, R3b, R3c, R4, R5 et p sont tels que définis ici, qui sont des inhibiteurs de la NS5b polymérase du virus de lhépatite C. Linvention concerne également des compositions et des procédés destinés à traiter une infection par le VHC et à inhiber la réplication du VHC.
Li Jim
Lui Alfred Sui-Ting
Mccaleb Kristen Lynn
Talamas Francisco Xavier
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Heterocyclic antiviral arylpyridone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic antiviral arylpyridone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic antiviral arylpyridone derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1961834